电子术中放疗与全乳外照射在合适乳腺癌患者中的疗效比较
单中心回顾性队列研究纳入204例合适乳腺癌患者,比较电子术中放疗(IORT)与全乳外照射(EBRT)的肿瘤学结局。中位随访5.1年,IORT组5年无病生存率95.61%低于EBRT组98.08%(P=0.02),局部控制率和乳腺癌特异性生存率两组无统计学差异。结论认为电子IORT应谨慎用于优先考虑治疗便利性的患者。
要点
- 电子IORT组5年无病生存率显著低于全乳EBRT组(95.61% vs 98.08%,P=0.02)。
- 两组5年局部控制率和乳腺癌特异性生存率无统计学差异。
- 接受全身治疗是无病生存的显著保护因素(HR 0.09,95%CI 0.01-0.74)。
核心结论
- 在合适选择的乳腺癌患者中,电子IORT相比全乳EBRT与5年无病生存率轻度但统计学显著的降低相关。
- 两组乳腺癌特异性生存率保持可比。
- 电子IORT应谨慎使用,并保留给优先考虑治疗便利性的患者。
研究设计与样本
- 单中心回顾性队列研究,2011年1月至2021年12月共纳入204例合格患者,其中IORT组74例、EBRT组130例。
- 中位随访时间为5.1年。
- 终点包括无病生存(DFS)、局部控制和乳腺癌特异性生存(BCSS)。
主要发现
- 5年DFS率:IORT组95.61%,EBRT组98.08%(log-rank P=0.02)。
- 单因素分析中,接受全身治疗是DFS的显著保护因素(HR 0.09,95%CI 0.01-0.74)。
- 接受全乳EBRT与事件风险降低相关,但未达统计学显著(HR 0.12,95%CI 0.02-1.01)。
临床怎么用
- 电子IORT可作为优先考虑治疗便利性患者的选项,但需告知其5年DFS可能略低于全乳EBRT。
- 选择电子IORT时应评估患者是否接受全身治疗,因其与DFS改善显著相关。
局限性
- 单中心回顾性设计,样本量有限(共204例),可能存在选择偏倚。
- 局部控制率和BCSS率的组间比较未达统计学显著,可能受样本量和事件数限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Intraoperative radiation therapy (IORT) with electrons is associated with higher rates of ipsilateral breast tumor recurrence in early-stage breast cancer than whole-breast external beam radiation therapy (EBRT). Although limited randomized and retrospective data suggest that this approach may suit a subset of patients, its role remains uncertain. This study aimed to compare oncological outcomes between technically optimal IORT with electrons and whole-breast EBRT in suitable patients with breast cancer. METHODS AND MATERIALS: In this single-center retrospective cohort study, patients were grouped by radiation treatment: IORT with electrons or whole-breast EBRT. Endpoints included disease-free survival (DFS), local control, and breast cancer-specific survival (BCSS). RESULTS: From January 2011 to December 2021, 204 eligible patients were reviewed (IORT, 74; EBRT, 130). The median follow-up was 5.1 years. The 5-year DFS rates were 95.61% for IORT and 98.08% for EBRT (log-rank P = .02). The 5-year local control rates were 98.46% for IORT and 100% (no event) for EBRT (log-rank P = .07). The 5-year BCSS rates were comparable: 98.61% for IORT and 100% (no event) for EBRT (log-rank P = .23). On univariable analysis for DFS, receipt of systemic treatment was a statistically significant protective factor (hazard ratio, 0.09; 95% CI, 0.01-0.74). Receipt of whole-breast EBRT was associated with a reduced risk of events, although this did not reach statistical significance (hazard ratio, 0.12; 95% CI, 0.02-1.01). CONCLUSIONS: IORT with electrons was associated with a modest but statistically significant reduction in 5-year DFS in appropriately selected patients compared with whole-breast EBRT, whereas BCSS remained comparable between groups. Therefore, electron-based IORT should be approached with caution and reserved for patients who prioritize treatment convenience.
引用
- Jitwatcharakomol T, Setakornnukul J, Chuthapisith S, et al. Outcomes of Technically Optimal Intraoperative Radiation Therapy With Electrons Versus Whole-Breast External Beam Radiation in Suitable Patients With Breast Cancer. Adv Radiat Oncol. 2026. PMID: 42472265. doi:10.1016/j.adro.2026.102086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。